PI3K/AKT pathway regulates E‐cadherin and Desmoglein 2 in aggressive prostate cancer
Publisher: John Wiley & Sons Inc
E-ISSN: 2045-7634|4|8|1258-1271
ISSN: 2045-7634
Source: Cancer Medicine, Vol.4, Iss.8, 2015-08, pp. : 1258-1271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract